文献速递病毒性肝炎

类风湿因子与IgM标记丙型肝炎相关混合冷球蛋白血症:一项8年前瞻性研究

Rheumatoid factor and immunoglobulin M mark hepatitis C-associated mixed cryoglobulinaemia: an 8-year prospective study.
PubMed 文献 · Clin Microbiol Infect · 2019-06-20

本研究对678例台湾慢性HCV感染者进行8年前瞻性队列研究,64.5%存在混合冷球蛋白血症,2.9%有混合冷球蛋白血症综合征。基线IgM、甘油三酯、IgG水平和HCV基因3型独立关联混合冷球蛋白血症,RF水平关联综合征。获得SVR者治愈率更高、持续率更低,治疗后IgM水平与长期混合冷球蛋白血症相关。

要点

  • 慢性HCV感染者中混合冷球蛋白血症患病率高达64.5%。
  • 基线RF水平关联混合冷球蛋白血症综合征,IgM水平关联混合冷球蛋白血症。
  • SVR患者混合冷球蛋白血症治愈率更高、持续率更低。

核心结论

  • 超过60%的慢性HCV感染者存在混合冷球蛋白血症,SVR患者治疗后8年仍有17.64%存在混合冷球蛋白血症。
  • 治疗前RF和IgM水平分别标记HCV相关的混合冷球蛋白血症综合征和混合冷球蛋白血症。

研究设计与样本

  • 8年前瞻性队列研究,纳入678例连续台湾慢性HCV感染者,其中438例完成抗HCV治疗疗程。

主要发现

  • 678例中437例(64.5%)有混合冷球蛋白血症,20例(2.9%)有混合冷球蛋白血症综合征。
  • 基线IgM(cut-off >122 mg/dL)、甘油三酯、IgG水平和HCV基因3型独立关联混合冷球蛋白血症。
  • RF水平关联混合冷球蛋白血症综合征(cut-off >12.2 IU/mL)。
  • 治疗24周后,362例SVR者治愈率29.3%(106/362)高于非SVR者13.2%(10/76),p=0.003;持续率27.6%(100/362)低于非SVR者43.4%(33/76),p=0.003。
  • SVR患者中,除新发混合冷球蛋白血症者外,RF、IgG和IgM水平较基线下降。

关键数值与推荐

  • 基线IgM cut-off >122 mg/dL、RF cut-off >12.2 IU/mL。
  • 治疗前IgM水平关联SVR患者治疗后24周新发混合冷球蛋白血症(OR 95%CI 1.002-1.023)和持续性混合冷球蛋白血症(OR 95%CI 1.004-1.015)。
  • SVR患者治疗后24周IgM水平关联长期混合冷球蛋白血症(9/51;17.64%;HR 95%CI 1.004-1.011)。

临床怎么用

  • 对慢性HCV感染者应关注混合冷球蛋白血症,基线可检测RF和IgM水平辅助风险评估。
  • 实现SVR可提高混合冷球蛋白血症治愈率并降低持续率,但部分患者仍长期存在。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The prevalence and factors of hepatitis C virus (HCV) -associated mixed cryoglobulinaemia in Asia remain elusive, and we aimed to investigate these topics. METHODS: An 8-year prospective cohort study was conducted in 678 consecutive Taiwanese individuals with chronic HCV infection (438 completed an anti-HCV therapy course). RESULTS: Of 678 individuals, 437 (64.5%) had mixed cryoglobulinaemia and 20 (2.9%) had mixed cryoglobulinaemic syndrome. At baseline, IgM (cut-off >122 mg/dL), triglycerides and IgG levels, and HCV genotype 3 were independently associated with mixed cryoglobulinaemia. Rheumatoid factor (RF) levels were associated with mixed cryoglobulinaemic syndrome (cut-off >12.2 IU/mL). At 24 weeks post-therapy, the 362 individuals with a sustained virological response (SVR) had higher cured (106/362 (29.3%) versus 10/76 (13.2%), p = 0.003) and lower persistent (100/362 (27.6%) versus 33/76 (43.4%), p = 0.003) mixed cryoglobulinaemia rates than non-SVR patients. Among SVR patients, compared with baseline levels, RF, IgG and IgM levels decreased, except in individuals with new mixed cryoglobulinaemia. Pre-therapy IgM levels were associated with 24-week post-therapy new (95% CI of OR 1.002-1.023) and persistent (95% CI of OR 1.004-1.015) mixed cryoglobulinaemia in SVR patients. After up to 8 years, 24-week post-therapy IgM levels were associated with mixed cryoglobulinaemia in SVR patients (9/51; 17.64%; 95% CI of HR 1.004-1.011). Among 17 SVR patients with pre-therapy mixed cryoglobulinaemic syndrome, 5 (29.4%) had long-term mixed cryoglobulinaemia and 4 (23.5%) had mixed cryoglobulinaemic syndrome. CONCLUSIONS: Over 60% of chronic HCV-infected individuals had mixed cryoglobulinaemia, and 17.64% of SVR patients had mixed cryoglobulinaemia 8 years post-therapy. Pre-therapy RF and IgM levels marked HCV-associated mixed cryoglobulinaemic syndrome and mixed cryoglobulinaemia, respectively.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Cheng YT, Cheng JS, Lin CH, et al. Rheumatoid factor and immunoglobulin M mark hepatitis C-associated mixed cryoglobulinaemia: an 8-year prospective study. Clin Microbiol Infect. 2019. PMID: 31229596. doi:10.1016/j.cmi.2019.06.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。